Skip to Content

ML P19 8 mg (Doxazosin Mesylate 8 mg)

Pill with imprint ML P19 8 mg is Green, Elliptical / Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Dava Pharmaceuticals Inc..

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ML P19 8 mg

Doxazosin mesylate 8 mg ML P19 8 mg
Doxazosin mesylate 8 mg ML P19 8 mg Front
Doxazosin mesylate 8 mg ML P19 8 mg Back
Doxazosin mesylate 8 mg ML P19 8 mg

Doxazosin Mesylate

ML P19 8 mg
8 mg
Elliptical / Oval
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dava Pharmaceuticals Inc.
Inactive Ingredients:
microcrystalline cellulose
magnesium stearate
sodium lauryl sulfate
FD&C Blue No. 2
D&C Yellow No. 10
aluminum oxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.